Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To assess the urodynamic findings in patients with Parkinson disease (PD) with overactive bladder symptoms. Methods: We performed a retrospective chart review of all PD patients who were seen in an outpatient clinic for lower urinary tract symptoms (LUTS) between 2010 and 2017 in a single-institution. Only patients who complained of overactive bladder (OAB) symptoms and underwent a video-urodynamic study for these symptoms were included. We excluded patients with neurological disorders other than PD and patients with voiding LUTS but without OAB symptoms. Results: We included 42 patients (29 men, 13 women, 74.5±8.1 years old). Seven patients (16.7%) had a postvoid residual (PVR) bladder volume >100 mL and only one reported incomplete bladder emptying. Detrusor overactivity (DO) was found in all 42 patients (100%) and was terminal in 19 (45.2%) and phasic in 22 patients (52.4%). Eighteen patients had detrusor underactivity (DU) (42.3%). Later age of PD diagnosis was the only parameter associated with DU (P=0.02). Patients with bladder outlet obstruction (BOO) were younger than patients without BOO (70.1 years vs. 76.5 years, P=0.004), had later first sensation of bladder filling (173.5 mL vs. 120.3 mL, P=0.02) and first involuntary detrusor contraction (226.4 mL vs. 130.4 mL, P=0.009). Conclusions: DO is almost universal in all patients with PD complaining of OAB symptoms (97.1%). However, a significant percentage of patients also had BOO (36.8%), DU (47%), and increased PVR (16.7%) indicating that neurogenic DO may not be the only cause of OAB symptoms in PD patients.
Abstract
Purpose: To assess the urodynamic findings in patients with Parkinson disease (PD) with overactive bladder symptoms. Methods: We performed a retrospective chart review of all PD patients who were seen in an outpatient clinic for lower urinary tract symptoms (LUTS) between 2010 and 2017 in a single-institution. Only patients who complained of overactive bladder (OAB) symptoms and underwent a video-urodynamic study for these symptoms were included. We excluded patients with neurological disorders other than PD and patients with voiding LUTS but without OAB symptoms. Results: We included 42 patients (29 men, 13 women, 74.5±8.1 years old). Seven patients (16.7%) had a postvoid residual (PVR) bladder volume >100 mL and only one reported incomplete bladder emptying. Detrusor overactivity (DO) was found in all 42 patients (100%) and was terminal in 19 (45.2%) and phasic in 22 patients (52.4%). Eighteen patients had detrusor underactivity (DU) (42.3%). Later age of PD diagnosis was the only parameter associated with DU (P=0.02). Patients with bladder outlet obstruction (BOO) were younger than patients without BOO (70.1 years vs. 76.5 years, P=0.004), had later first sensation of bladder filling (173.5 mL vs. 120.3 mL, P=0.02) and first involuntary detrusor contraction (226.4 mL vs. 130.4 mL, P=0.009). Conclusions: DO is almost universal in all patients with PD complaining of OAB symptoms (97.1%). However, a significant percentage of patients also had BOO (36.8%), DU (47%), and increased PVR (16.7%) indicating that neurogenic DO may not be the only cause of OAB symptoms in PD patients.
참고문헌 (28)
- National Collaborating Centre for Chronic Conditions, "Parkinson’s disease: national clinical guideline for diagnosis and management in primary and secondary care", pp.121~124 (2006), Royal College of Physicians
- Sakakibara R, "Urological dysfunction in synucleinopathies : epidemiology, pathophysiology and management", Clin Auton Res, 28, pp.83~101 (2018)
- McDonald C, "Lower urinary tract symptoms in Parkinson’s disease : prevalence, aetiology and management", Parkinsonism Relat Disord, 35, pp.8~16 (2017)
- Brucker BM, "Parkinson’s disease and its effect on the lower urinary tract : evaluation of complications and treatment strategies", Urol Clin North Am, 44, pp.415~428 (2017)
- Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease, "The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations", Mov Disord, 18, pp.738~750 (2003)
- Tomlinson CL, "Systematic review of levodopa dose equivalency reporting in Parkinson’s disease", Mov Disord, 25, pp.2649~2653 (2010)
- Schäfer W, "Good urodynamic practices : uroflowmetry, filling cystometry, and pressure-flow studies", Neurourol Urodyn, 21, pp.261~274 (2002)
- Abrams P, "Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency : three simple indices to define bladder voiding function", BJU Int, 84, pp.14~15 (1999)
- Chassagne S, "Proposed cutoff values to define bladder outlet obstruction in women", Urology, 51, pp.408~411 (1998)
- Nitti VW, "Diagnosing bladder outlet obstruction in women", J Urol, 161, pp.1535~1540 (1999)
- Gammie A, "What are the additional signs and symptoms in patients with detrusor underactivity and coexisting detrusor overactivity?", Neurourol Urodyn, 37, pp.2220~2225 (2018)
- Rosier PF, "Do patients with symptoms and signs of lower urinary tract dysfunction need a urodynamic diagnosis? ICI-RS 2013", Neurourol Urodyn, 33, pp.581~586 (2014)
- Rachaneni S, "Effectiveness of BTX-A and neuromodulation in treating OAB with or without detrusor overactivity : a systematic review", Int Urogynecol J, 28, pp.805~816 (2017)
- Ogawa T, "Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy", Nat Rev Urol, 14, pp.79~89 (2017)
- Araki I, "Voiding dysfunction and Parkinson’s disease : urodynamic abnormalities and urinary symptoms", J Urol, 164, pp.1640~1643 (2000)
- Gray R, "Lower urinary tract dysfunction in Parkinson’s disease : changes relate to age and not disease", Age Ageing, 24, pp.499~504 (1995)
- Kitta T, "Brain activation during detrusor overactivity in patients with Parkinson’s disease: a positron emission tomography study", J Urol, 175(3 Pt 1), pp.994~998 (2006)
- Hamill RW, "Autonomic dysfunction and plasticity in micturition reflexes in human α-synuclein mice", Dev Neurobiol, 72, pp.918~936 (2012)
- Andersson KE, "Storage and voiding symptoms: pathophysiologic aspects", Urology, 62(5 Suppl 2), pp.3~10 (2003)
- Defreitas GA, "Distinguishing neurogenic from non-neurogenic detrusor overactivity : a urodynamic assessment of lower urinary tract symptoms in patients with and without Parkinson’s disease", Urology, 62, pp.651~655 (2003)
- Sakakibara R, "Videourodynamic and sphincter motor unit potential analyses in Parkinson’s disease and multiple system atrophy", J Neurol Neurosurg Psychiatry, 71, pp.600~606 (2001)
- Kim M, "Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson’s disease", Parkinsonism Relat Disord, 21, pp.205~210 (2015)
- Uren AD, "Qualitative exploration of the patient experience of underactive bladder", Eur Urol, 72, pp.402~407 (2017)
- Roth B, "Benign prostatic obstruction and parkinson’s disease--should transurethral resection of the prostate be avoided?", J Urol, 181, pp.2209~2213 (2009)
- Vurture G, "Outcomes of intradetrusor onabotulinum toxin A injection in patients with Parkinson’s disease", Neurourol Urodyn, 37, pp.2669~2677 (2018)
- Hennessey DB, "Sacral neuromodulation for detrusor hyperactivity with impaired contractility", Neurourol Urodyn, 36, pp.2117~2122 (2017)
- Wang CC, "Efficacy and safety of intravesical OnabotulinumtoxinA injection in patients with detrusor hyperactivity and impaired contractility", Toxins (Basel), 8(3), pp.E82~ (2016)[DOI]
- Dmochowski RR, "Female voiding dysfunction and movement disorders", Int Urogynecol J Pelvic Floor Dysfunct, 10, pp.144~151 (1999)